Incyte Corporation INCY 124.64 -180.41% NMS · Healthcare
Open terminal

Incyte Corporation (incy)

Unlock full data in Terminal →

INCY Dividends

Dividend yieldNot applicable
Forward P/E14.03

The figure above is this ticker’s indicated or trailing dividend yield. Yield means annual dividend divided by the current share price. A 12-month (TTM) yield uses dividends already paid; the forward yield uses the expected next year. Dividend yield meaning — then confirm the live payout for Incyte Corporation (INCY) in Vest Terminal.

Start Free — open INCY in Vest Terminal

Access live data, filings, ownership, and analysis for Incyte Corporation.

Create free account See plans

Incyte Corporation FAQ

What does Incyte Corporation (INCY) do?

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refrac…

What is INCY's P/E ratio?

Incyte Corporation has a trailing P/E of 16.17× based on publicly available market data.

Does INCY pay a dividend?

Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.

What sector is INCY in?

Incyte Corporation is classified in Healthcare (Biotechnology) on NMS.

What is INCY's market capitalization?

Approximate market cap: $25.26B.

What are the main risks for INCY?

Standard market, competitive, and execution risks apply; see the Risks section.

What are the strengths of INCY?

Potential positives include revenue growth of 37.7% year-over-year, earnings growth of 37.7% year-over-year.

Where can I get analyst estimates for INCY?

Public analyst price targets and consensus for Incyte Corporation are on the free /stocks/incy/estimates page. Deeper estimate history and models are available in Vest Terminal.